Home

Health Care Reform

BIO Media Briefing: Healthcare Reform Should Preserve Innovation

BIO President and CEO Jim Greenwood and BIO Board Chair Dr. Stephen Sherwin discuss the need to ensure that health care reform promotes and preserves innovation, particularly in a pathway for biosimilars and the use of comparative effectiveness data.

BIO's Principles for Payment System Reform (PSR) Policies
Health Reform Debate Heats Up and Slows Down

The health reform debate is heating up and, in at least one respect, slowing down a bit.

BIO’s Principles on Universal Access to Health Care
Guide to Biotechnology 2008

We have used the biological processes of microorganisms for 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

From the Hill to the Street: Examining Policy Issues in Biotech

Letters, Testimony & Comments

EHB: BIO’s Comments on the Essential Health Benefits Proposed Rule
December 21 2012
          The Biotechnology Industry Organization (BIO) is pleased to submit the following...
Biosimilar Patent Certification: University Associations Ask FDA to Not Undermine Their Patent Rights
November 5 2012
Dear Commissioner Hamburg: We are writing on behalf of the following higher education associations in consideration of issues raised...
CER: BIO’s comments on PCORI’s Draft Methodology Report
September 13 2012
Re:  Patient-Centered Outcomes Research Institute (PCORI) Draft Methodology Report Dear Dr. Selby: The Biotechnology Industry...
2012 AMP Proposed Rule: BIO's Comments on the Centers for Medicare and Medicaid Services’ Proposed Rule regarding covered outpatient drugs under the Medicaid Program
April 1 2012
Re:      CMS-2345-P (Proposed Rule, Medicaid Program; Covered Outpatient Drugs) Dear Ms. Tavenner: The...
BIO's Testimony to the Senate Health, Education, Labor, and Pensions Full Committee Hearing on the FY2012 FDA User Fee Agreements
March 29 2012
 Chairman Harkin, Ranking Member Enzi, Members of the Committee, it is my privilege to provide testimony before you today. My name...
More Letters, Testimony & Comments →

Press Releases

Supreme Court Affordable Care Act Ruling Must Now Lead to Implementation That Will Promote Innovation and Expand Access
June 28 2012
  Pleased to move forward on biosimilars pathway Washington, D.C. (June 28, 2012) –Biotechnology...
TREAT Act Offers Renewed Hope for Patients
February 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay...
BIO Statement on Health Care Reform
March 22 2010
WASHINGTON, D.C. (Monday, March 22, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim...
Provisions in the Senate Health Care Bill Help Patients, Promote Innovation, Encourage Job Growth
December 24 2009
WASHINGTON, D.C. (Friday, December 25, 2009) - Biotechnology Industry Organization (BIO) President and CEO Jim...
Eighth Annual BIO Investor Forum to Address Health Care Reform, Current Issues and Opportunities in the Biotech Industry
October 15 2009
WASHINGTON, D.C. (Thursday, October 15, 2009) - The Biotechnology Industry Organization (BIO) today announced Plenary...